We are living in an era where our working environment is drastically changing. Technology has become one of the key components of organisations across all types of businesses, whether it's a multinational corporation or an SME, and our reliance will only increase. We are in the midst of another industrial revolution that shows no sign of slowing down and IT firms are reaping the benefits of this.
The message of our new campaign is one that I hope will make people not just stop and take notice, but stop and take action: 'It's time to swear to take on mental illness in young people'. Why swearing? Because it perfectly encompasses how so many of us feel about the state of mental healthcare today.
What is left to say about the US election and Brexit? There seems to be a sense of fatigue now when people discuss these two events - a sense of disbelief and tiredness. However, the implications of both are so huge that we can't shy away from it and have to push ahead; not only to understand what's next, but how it all happened in the first place.
Explaining the US health system to UK and European audiences can be a challenge. In the US, access to affordable healthcare is a very emotive subject, attracting strong opinions across the spectrum. With the new President-elect heralding a shake-up for Obamacare - which was introduced to provide greater access to healthcare - emotions are likely to rise higher over coming months as this policy becomes a key area of focus for the new administration.
I'm using the 'festive fear' as a collective term for negative feelings of stress, anxiety and irrational thoughts during the Christmas period. These could be feelings of financial stress, anxiety about seeing family members who've had rifts with in the past or perhaps obsessive irrational thoughts concerning your hosting skills or the gifts you've bought.
As the work begins and the dust starts to settle on this year's Autumn Statement, I think we can see it as a real shot in the arm for infrastructure, R&D and innovation. These measures should see a real return in terms of productivity and growth. They should, too, help the UK keep up in telecomms developments. And they present a great opportunity to push even harder on urban innovation, so our companies can continue to develop and sell world-beating products and services that help cities thrive.
I had a piece of fantastic news last week, one of those breakthrough moments that all of us who work in and support the charity sector aim for. On the surface it may not sound that exciting. The news was that NICE, after undertaking an exceptional review, had agreed to update its guidelines for prostate cancer diagnosis and management
Most clinical trials compare the drug to another treatment- either a dummy drug (placebo) or an alternative treatment, which is already approved for treating people. This is called a double-blind study. This design gives the most reliable results, as it confirms that any benefit is genuinely due to the new drug. However it means some people won't receive the new treatment.